NMN Hard Capsules — The Most Clinically Validated NAD+ Precursor, Engineered for Brand Credibility


Payment Terms:

TT/LC/DP/PayPal/Western Union

Delivery Time:

3-4 weeks

MOQ:

2000 bottles


FDA
cGMP
ISO9001
ISO22000
HACCP
FSSC22000
HALAL
SC
REACH
DGM
DMF
ECOCERT
Eurofins
SGS

Product Description

Over the past three years, we've reviewed dozens of NMN products from brands that came to us after their initial manufacturer disappointed them. The complaints are always different — "NAD+ levels didn't change," "the capsules clumped after three months," "our customers said it didn't feel different" — but the root cause is usually the same.

The NMN market has become a race to the bottom on price, with factories competing on who can claim the highest purity at the lowest cost. But here's what we've learned from 28 years of capsule manufacturing and over 3,000 brand partnerships: purity on a certificate of analysis is not the same as purity inside the capsule on your shelf six months from now.

NMN (β-Nicotinamide Mononucleotide) is a hygroscopic molecule — it attracts water from the air. In environments above 60% relative humidity or temperatures above 40°C, it degrades into nicotinamide and nicotinic acid, losing the very biological activity your customers are paying for. And unlike some actives, you can't see or smell this degradation happening.

The brands that succeed in the NMN category aren't the ones with the cheapest raw material. They're the ones whose manufacturing partner understands moisture control, isomer verification, and how to build a formulation story backed by actual clinical data — not marketing hype.

That's what this page is about.


Product Specifications

Parameter

Details

Active Ingredient

β-Nicotinamide Mononucleotide (β-NMN)

CAS Number

1094-61-7

Molecular Formula

C₁₁H₁₅N₂O₈P (MW: 334.22 g/mol)

Dosage Strength

100mg / 250mg / 300mg / 500mg / 600mg per capsule

Purity

≥98% (β-NMN, verified by HPLC)

Shell Type

HPMC (vegetarian/vegan) or Gelatin

Capsule Sizes

#00, #0, #1 (based on dosage)

Shelf Life

24 months (ambient, with moisture-barrier packaging)

Production Capacity

1.6 million capsules/day

MOQ

2,000 bottles

Lead Time

3-4 weeks after approval

Certifications

ISO9001, ISO22000, FSSC22000, GMP, FDA-registered, HALAL, SC, REACH, ECOCERT


Why NMN: The Clinical Foundation Your Brand Can Build On

Before discussing manufacturing, let's address the science — because in the NAD+ precursor market, your brand's credibility depends on claims you can actually support.

NMN is the most clinically studied NAD+ precursor available. Here's what the published human data actually shows:

Dose-response evidence (2022, multicenter trial, n=80):

Oral NMN at 300mg, 600mg, and 900mg daily significantly increased blood NAD+ levels after 30 days, with the most pronounced elevation at 600-900mg doses. No safety concerns were reported, and physical performance improvements were observed.

Metabolic health (2021, Washington University):

250mg of oral NMN daily for 10 weeks improved muscle insulin sensitivity in prediabetic women — a measurable physiological change, not just a biomarker shift.

Healthy aging in older adults (2022, Japanese RCT):

250mg oral NMN daily for 12 weeks improved walking speed and sleep quality in older Japanese adults, with statistically significant results versus placebo.

Head-to-head comparison (2025, Nature Metabolism, Nestlé Health Science):

In the first published human trial directly comparing NMN, NR, and Nicotinamide, both NMN (1g/day) and NR (1g/day) doubled circulating NAD+ after 14 days. Nicotinamide showed only an acute, transient effect at 4 hours — no sustained elevation. Critically, this study also revealed that gut microbiota convert NMN to nicotinic acid (NA), a potent NAD+ precursor, while simultaneously increasing short-chain fatty acid (SCFA) concentrations — suggesting NMN supports gut health through its microbiome interactions.

Long-term safety (multiple trials):

Oral NMN at doses up to 1,250mg daily has been well-tolerated across multiple clinical studies with no serious adverse events. Abinopharm's AbinoNutra® NMN holds Self-Affirmed GRAS status based on human clinical data at 300mg, 600mg, and 900mg daily doses.

What this means for your brand:

NMN isn't a speculative ingredient — it's the most evidence-backed NAD+ precursor on the market. Your product claims can reference specific dose ranges (250-900mg), specific durations (14-90 days in clinical studies), and specific outcomes (NAD+ elevation, muscle insulin sensitivity, physical performance). No other NAD+ precursor offers this depth of published human data.


How NMN Actually Works in the Body — And Why It Matters for Your Formulation

Understanding NMN's absorption mechanism isn't academic — it directly affects how you position your product.

The Slc12a8 transporter discovery:

For years, researchers assumed NMN had to convert to nicotinamide riboside (NR) before entering cells. In 2019, Grozio et al. discovered that the small intestine expresses a dedicated transporter — Slc12a8 — that specifically recognizes and shuttles intact NMN molecules directly into cells. This sodium-dependent transporter is concentrated in the jejunum and ileum, the core nutrient absorption zones.

Practical implications:

  • NMN enters blood circulation within 2.5-10 minutes of oral intake (isotope-labeled studies)
  • Liver conversion to NAD+ begins within 15-30 minutes
  • The dedicated transporter means oral capsules work — there's no requirement for sublingual or liposomal delivery
  • Every major published clinical trial used standard oral administration (capsules or powder with water)

The sublingual myth:

Some brands market sublingual NMN as having 2-3× higher bioavailability than capsules. Here's the reality: no peer-reviewed human study has ever directly compared sublingual versus oral NMN absorption. Every clinical trial proving NMN's benefits used standard oral dosing. The "sublingual advantage" claim is extrapolation without evidence.

For your brand, this means: standard hard capsules are the most clinically validated delivery format for NMN. Delayed-release (enteric-coated) capsules offer an option for brands wanting to position against gastric degradation concerns, but the core clinical data supports simple oral administration.


The Manufacturing Gap: What "99% Purity" Doesn't Tell You

Walk into any contract manufacturer's facility and ask about their NMN quality control. You'll hear "≥99% purity" repeated like a mantra. But that single number obscures three critical questions that determine whether your product will actually perform:

1. Isomer Identity: β-NMN vs α-NMN

NMN exists in two isomeric forms: β-NMN and α-NMN. Only β-NMN is the biologically active form recognized by human enzymes (NMNAT) and the Slc12a8 transporter. α-NMN has no demonstrated biological activity for NAD+ synthesis.

Low-grade NMN raw material — particularly from chemical synthesis routes — may contain significant proportions of α-NMN or degraded nicotinamide. Enzymatic fermentation produces predominantly β-NMN, which is why the highest-quality suppliers use biological production methods.

Our standard: All NMN raw material is verified as ≥98% β-NMN by HPLC before production begins. Every batch includes isomer profile documentation, not just total NMN content.

2. Moisture Control: The Invisible Threat

NMN is hygroscopic — it absorbs water from the surrounding environment. Once moisture content rises, degradation accelerates:

  • Above 60% RH: Degradation rate increases significantly
  • Above 40°C: Thermal degradation compounds the problem
  • Degradation products: Nicotinamide and nicotinic acid — the very molecules NMN is supposed to help your body convert naturally

Most contract manufacturers don't discuss their humidity controls because they don't have meaningful ones. Here's what we do:

Control Point

Our Standard

Industry Typical

Raw material storage

<40% RH, nitrogen-sealed

Ambient warehouse

Production environment

≤45% RH, D-grade cleanroom

General workshop

Temperature

18-26°C controlled

Seasonal variation

Blending to encapsulation

<30 minutes exposure

Uncontrolled

In-process protection

Nitrogen blanket throughout

Open-air filling

Finished product

Moisture-barrier bottle + desiccant

Standard HDPE bottle

The result: NMN capsules that maintain labeled potency through their full 24-month shelf life, not just on the day they're manufactured.

3. Stability Data: Claims vs Evidence

Every manufacturer claims "24-month shelf life." How many can show you the stability study behind that claim?

We conduct both real-time and accelerated stability testing on every NMN formulation, tracking:

  • Active potency (HPLC assay at 0, 3, 6, 12, 18, 24 months)
  • Degradation products (nicotinamide, nicotinic acid quantification)
  • Moisture content (Karl Fischer titration)
  • Capsule integrity (disintegration time, dissolution)
  • Microbiological compliance

Your brand gets a complete stability dossier — not just a Best-Before date printed on the bottle.


NMN vs Other NAD+ Precursors: Positioning Your Brand with Scientific Clarity

The NAD+ precursor market includes several molecules, and your customers will encounter comparisons whether you address them or not. Better to own the conversation:

Parameter

NMN

NR

Nicotinamide (NAM)

NMNH

Molecular form

Nucleotide monophosphate

Nucleoside

Vitamin B3 form

Reduced nucleotide

MW (g/mol)

334.22

255.25

122.12

336.24

Cellular entry

Slc12a8 transporter (direct)

NRK1/NRK2 phosphorylation → NMN → NMNAT

NAMPT-dependent (rate-limited)

NMNAT (direct, bypasses NAMPT/NRK)

Bypasses NAMPT bottleneck

Yes

Partially (needs NRK)

No (NAMPT-dependent)

Yes

Clinical evidence depth

Multiple published human trials (250-900mg, 14-90 days)

Multiple published human trials (100-1000mg)

Limited sustained effect

Limited (1 unpublished 90-day trial)

Circulating NAD+ elevation (14 days)

~2× (1g/day)

~2× (1g/day)

Acute only (no sustained effect)

~3× (500mg/day, unpublished)

Gut microbiome interaction

Converts to NA via gut bacteria; increases SCFAs

Similar microbiome conversion to NA

No documented microbiome effect

Not studied

Sirtuin inhibition risk

Low

Low

Yes (at 30-200μM)

Low

Key advantage

Most validated, dedicated transporter

Smaller molecule, broader tissue distribution

Cheapest, widely available

Bypasses all enzymatic bottlenecks

Market maturity

Highest (dominant NAD+ precursor market share)

High (Tru Niagen, ChromaDex)

Low (commodity)

Emerging

The NMN positioning advantage: Your brand can reference specific, published human clinical data at defined doses — something neither NMNH nor most NR products can match yet. The 2025 Nature Metabolism head-to-head trial directly validated NMN's equivalence to NR for sustained NAD+ elevation, while demonstrating NAM's inadequacy.


Formulation Strategy: Building NMN Products That Tell a Complete Story

Single-ingredient NMN products work. But the brands that command premium pricing and customer loyalty tend to build their NMN line around synergistic combinations that address the full NAD+ lifecycle:

Tier 1: NMN Essential (Entry-Level Longevity)

Per serving (2 capsules):

  • β-NMN: 300mg
  • Trans-Resveratrol (from Japanese Knotweed): 100mg

Positioning: The scientifically classic longevity pairing. NMN fuels NAD+ production; Resveratrol activates SIRT1 pathways that depend on NAD+. Together, they cover both sides of the NAD+-sirtuin axis.

Tier 2: NMN Advanced (Comprehensive NAD+ Support)

Per serving (2 capsules):

  • β-NMN: 500mg
  • Trans-Resveratrol: 150mg
  • Coenzyme Q10 (Ubiquinone): 50mg

Positioning: Adds mitochondrial electron transport support. While NMN regenerates NAD+ for metabolic reactions, CoQ10 supports the mitochondrial Complex I-III where NADH donates electrons for ATP production. This combination addresses both NAD+ regeneration and NADH utilization.

Tier 3: NMN Complete Longevity Stack (Premium Positioning)

Per serving (3 capsules):

  • β-NMN: 600mg
  • Trans-Resveratrol: 200mg
  • PQQ (Pyrroloquinoline Quinone): 20mg
  • Quercetin: 150mg
  • TMG (Trimethylglycine): 250mg

Positioning: The most scientifically complete NAD+ support formula. TMG addresses the methylation demand created by NMN metabolism — when NAD+ is metabolized, nicotinamide must be methylated (using SAMe) before excretion. TMG provides methyl groups to support this cycle, ensuring NMN is utilized efficiently without depleting the body's methylation capacity. Quercetin adds senolytic potential; PQQ supports mitochondrial biogenesis.

Why TMG matters (and most manufacturers don't include it):

NMN metabolism generates nicotinamide as a byproduct when NAD+ is consumed by sirtuins and PARPs. The liver methylates this nicotinamide (via NNMT) before renal excretion — a process that consumes S-adenosylmethionine (SAMe), the body's primary methyl donor. Over time, high-dose NMN without methyl support could theoretically increase methylation demand. TMG (betaine) provides an alternative methyl source, supporting the methylation cycle without relying solely on folate-dependent pathways.

This is the kind of formulation detail that separates a credible longevity brand from a commodity NMN product.


Quality Assurance: The Documentation Your Brand Needs for Global Markets

Selling NMN products requires navigating different regulatory frameworks depending on your target market:

Market

NMN Status

Key Requirement

United States

Dietary supplement (status under FDA review since 2022)

FDA-registered facility, cGMP compliance

European Union

Novel Food (requires pre-market authorization)

Full safety dossier, stability data

Japan

Approved food ingredient

JAS compliance, domestic or equivalent standards

Australia

Listed medicine (Aust L) or Registered medicine (Aust R)

TGA-licensed manufacturing

Middle East

Halal-certified ingredients required

HALAL certification throughout supply chain

What we provide with every batch:

  • Certificate of Analysis (COA): Identity, potency, heavy metals, microbiology, residual solvents
  • Isomer profile: β-NMN vs α-NMN ratio verification
  • Stability data: Accelerated and real-time study summaries
  • GMP batch record: Full traceability from raw material to finished product
  • Regulatory support documentation: For US, EU, and other target markets

Customization Options

Dosage Strength:

100mg / 250mg / 300mg / 500mg / 600mg per capsule — aligned with clinical dose ranges

Capsule Type:

  • HPMC (vegetarian/vegan): Standard or enteric-coated (delayed-release)
  • Gelatin: Standard two-piece hard capsule
  • Sizes: #00 (high-dose), #0 (mid-dose), #1 (lower-dose or combination formulas)

Formulation Options:

  • Single-ingredient NMN
  • NMN + Resveratrol combinations
  • NMN + TMG methylation support
  • NMN + CoQ10 mitochondrial support
  • Custom longevity stacks (NMN + PQQ + Quercetin + Apigenin + more)

Packaging:

  • HDPE bottles with induction seal + desiccant
  • Blister packs (Alu-Alu for moisture protection)
  • Private label: Custom bottle labels, cartons, inserts
  • Bulk packaging for secondary packaging partners

Labeling Compliance:

We support compliant labeling for US, EU, and other target markets — including supplement facts panel formatting, allergen declarations, and claim language review.


Frequently Asked Questions

Q: Why is β-NMN specifically important? Can't any NMN work?

A: Only β-NMN is the biologically active isomer recognized by the Slc12a8 transporter and NMNAT enzymes. α-NMN — which can be present in chemically synthesized NMN — has no demonstrated activity for NAD+ synthesis. This is why we verify isomer identity (not just total NMN content) on every batch using HPLC. Enzymatic fermentation produces predominantly β-NMN; chemical synthesis routes may yield significant α-NMN proportions.

Q: What's the difference between NMN capsules and sublingual NMN? Should I offer both?

A: All major published human clinical trials used oral NMN (capsules or powder with water) — not sublingual formulations. No peer-reviewed study has directly compared sublingual vs oral absorption in humans. The Slc12a8 transporter in the small intestine efficiently absorbs intact NMN molecules, with blood levels rising within 2.5-10 minutes. Standard hard capsules are the most clinically validated delivery format. Sublingual can be offered as a product line extension, but your core claims should reference oral clinical data.

Q: Why is TMG often paired with NMN? Is it necessary?

A: TMG (trimethylglycine) addresses a real metabolic consideration: when NAD+ is consumed by cellular enzymes (sirtuins, PARPs), the resulting nicotinamide must be methylated by the liver before excretion — a process that uses SAMe, the body's primary methyl donor. At higher NMN doses (500mg+), this methylation demand becomes significant. TMG provides an alternative methyl source, supporting the methylation cycle. It's not strictly "necessary" at lower doses, but including it in premium formulations addresses a legitimate biochemical consideration that discerning customers will ask about.

Q: Can NMN be combined with other active ingredients in the same capsule?

A: Yes. The most scientifically supported combinations include NMN + Resveratrol (NAD+ supply + SIRT1 activation), NMN + CoQ10 (NAD+ regeneration + mitochondrial electron transport), NMN + TMG (NAD+ support + methylation support), and NMN + PQQ (NAD+ support + mitochondrial biogenesis). We formulate and stability-test these combinations as complete products — not just single-ingredient capsules.

Q: What shelf life can I expect for NMN capsules?

A: With proper moisture-controlled manufacturing and moisture-barrier packaging (HDPE bottle with induction seal + desiccant, or Alu-Alu blister), NMN capsules maintain labeled potency for 24 months at ambient conditions (≤25°C, ≤60% RH). We provide complete stability study data (accelerated and real-time) with every batch — not just a printed expiration date.

Q: What's the MOQ and lead time?

A: Minimum order quantity is 2,000 bottles. Sample production takes 5-7 working days. Mass production lead time is 3-4 weeks after formula and artwork approval. We produce 1.6 million capsules per day across our capsule lines, so volume orders can be accommodated efficiently.


Ready to Build a Credible NMN Brand?

The NMN market rewards brands that can back their claims with manufacturing transparency — verified isomer purity, documented stability data, and formulations aligned with published clinical evidence.

Contact us to discuss your NMN capsule project. Send us your target market, preferred dosage, and formulation goals — we'll respond within 24 hours with a feasibility assessment and pricing structure.

Related articles:

Related Products:

Get a Free Quote

If you need more information about our products, please feel free to contact us, we will provide you with professional service personnel, we will reply promptly after receiving the information.

  • What products do you need?
  • How much do you need?
  • What other information do you need to know?
Security verification
Submit

FAQ

Q

Can you customize product formulations based on cross-border market demands?


A

Absolutely, we can tailor product formulations to meet local consumer preferences and regulatory requirements in your target markets.

Q

Can you provide multilingual labeling and instructions for cross-border products?


A

Certainly, we offer multilingual labeling and instructions to ensure accurate communication of product information in different countries' markets.

Q

What is the MOQ for cross-border business?


A

Our cross-border business MOQ is low, typically ranging from 1000 to 5000 units of products, and can be flexibly adjusted based on specific circumstances.

Q

Can you directly ship to overseas warehouses or facilitate split shipments?


A

We support direct delivery to overseas warehouses and can arrange split shipments according to your needs. We have well-established global logistics solutions.

Q

Do you support commonly used payment methods for cross-border markets?


A

Yes, we support widely used cross-border payment settlement methods such as PayPal, credit cards, and TT bank transfers.

Q

Can you provide import customs clearance documents for major countries?


A

Yes, we can provide customs registration information, inspection reports, and other customs clearance documents for different countries.

Q

Does your product packaging design comply with regulatory requirements in major countries?


A

Our product packaging design can be adjusted to meet the regulatory standards and requirements of different countries, ensuring compliance with local norms. 

Q

Can you conduct small-scale production for cross-border testing?


A

Certainly,we welcome small-scale trial orders. We have dedicated small-scale production lines available for cross-border market testing,assisting you in evaluating market potential and feedback.